Based on trial timelines, an FDA submission could occur in 20262027 with potential approval in 20272028
The L carnitine fat burner works by converting stored fat into usable energy, helping you train longer, recover faster, and achieve a leaner physique
On the heels of Regenerons combinations, Scholar Rocks released results from EMBRAZE, a 24-week Phase 2 study of tirzepatide with or without their anti-(latent) myostatin antibody, apetigromab
To get the best from both treatments, it's essential to make healthy lifestyle changes alongside them
This small but impactful treatment often leads to better mood, improved memory, and more productive days
Previous work has demonstrated that optogenetically stimulating D1 MSNs promotes reward, whereas stimulating D2 MSNs produces aversion